Implementation study of the CARRA Uveitis Consensus Treatment Plans: feasibility for clinical practice and applicability for research.

Autor: Chang, Margaret H.¹ (AUTHOR), Barbar-Smiley, Fatima² (AUTHOR), Akoghlanian, Shoghik³ (AUTHOR), Drew, Joanne³ (AUTHOR), Angeles-Han, Sheila T.^4,5 (AUTHOR), Quinlan-Waters, Megan⁴ (AUTHOR), Bohnsack, John F.⁶ (AUTHOR), Cooper, Ashley M.⁷ (AUTHOR), Edelheit, Barbara⁸ (AUTHOR), Twachtman-Bassett, Jennifer⁸ (AUTHOR), Lerman, Melissa A.⁹ (AUTHOR), Nanda, Kabita¹⁰ (AUTHOR), Rabinovich, C. Egla¹¹ (AUTHOR), Lo, Mindy S.¹ (AUTHOR) mindy.lo@childrens.harvard.edu, Aamir, R. (AUTHOR), Abulaban, K. (AUTHOR), Adams, A. (AUTHOR), Aguiar Lapsia, C. (AUTHOR), Akinsete, A. (AUTHOR), Al Manaa, M. (AUTHOR)

Publikováno v: Pediatric Rheumatology. 10/7/2024, Vol. 22 Issue 1, p1-10. 10p.

A Randomized Controlled Trial of OPT-302, a VEGF-C/D Inhibitor for Neovascular Age-Related Macular Degeneration

Autor: Kousal, Bohdan, Studnicka, Jan, Veith, Michal, Creuzot-Garcher, Catherine, De Bats, Flore, Gaucher, David, Mauget-Faysse, Martine, Souied, Eric, Tadayoni, Ramin, Facsko, Andrea, Kerénvi, Agnes, Papp, Andras, Tsorbatzoglou, Alexis, Vogt, Gabor, Barak, Yoreh, Chowers, Itay, Goldstein, Michaella, Hanhart, Joel, Morori-Katz, Haya, Rosenblatt, Irit, Rubowitz, Alexander, Netzer, Oren Tomkins, Bandello, Francesco, Ciardella, Antonio, Ricci, Federico, Staurenghi, Giovanni, Virgili, Gianni, Baumane, Kristine, Laganovska, Guna, Ozolina, Signe, Strautmane, Ilze, Kaluzny, Bartlomiej, Mackiewicz, Jerzy, Misiuk-Hoilo, Marta, Mrukwa-Kominek, Ewa, Oleksy, Piotr, Raczynska, Krystyna, Zarnowski, Tomasz, Adan, Alfredo, Araiz, Javier, Boixadera, Anna, Fernández-Vega, Alvaro, Layana, Alfredo Garcia, Gomez-Ulla, Francisco, Montero, Javier, Ruiz Moreno, Jose Maria, Gilmour, David, Jackson, Timothy, Liyanage, Sidath, Membrey, Luke, Menon, Geeta, Narendran, Niro, Sivaprasad, Sobha, Alfaro, Daniel, Antoszyk, Andrew, Baker, Carl, Batille, Ivan, Berger, Brian, Boyer, David, Bridges, William, Brooks, Harold, Brown, David, Chang, Margaret, Chao, Daniel, Chen, Sanford, Crawford, Courtney, Dugel, Pravin, Eaton, Alexander, Eichenbaum, David, Fein, Jordana, Feiner, Leonard, Flaxel, Christina, Garber, Frank, Gordon, Alan, Gupta, Sunil, Haegedorn, Curtis, Hampton, George, Hanscom, Thomas, Hershberger, Vrinda, Kaiser, Peter, Katz, Randy, Khanani, Arshad, Kruger, Erik, Marcus, Denis, Ohr, Matthew, Patel, Sunil, Pearlman, Joel, Pesavento, Richard, Pieramici, Dante, Pitcher, John, Prensky, Jay, Randolf, John, Regillo, Carl, Rose, Steven, Samuel, Michael, Schneiderman, Todd, Shah, Sumit, Singer, Michael, Steinle, Nathan, Stoller, Glenn, Thach, Alan, Thompson, John, Varenhorst, Michael, Wagner, Alan, Walker, Joseph, Wells, John, Williams, Jonathan, Wong, Robert, Wykoff, Charles, Jackson, Timothy L., Slakter, Jason, Buyse, Marc, Wang, Kun, Dugel, Pravin U., Wykoff, Charles C., Boyer, David S., Gerometta, Michael, Baldwin, Megan E., Price, Clare F.

Publikováno v: In Ophthalmology June 2023 130(6):588-597

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Archway Randomized Phase 3 Trial of the Port Delivery System with Ranibizumab for Neovascular Age-Related Macular Degeneration

Autor: Holekamp, Nancy M., Campochiaro, Peter A., Chang, Margaret A., Miller, Daniel, Pieramici, Dante, Adamis, Anthony P., Brittain, Christopher, Evans, Erica, Kaufman, Derrick, Maass, Katie F., Patel, Shienal, Ranade, Shrirang, Singh, Natasha, Barteselli, Giulio, Regillo, Carl

Publikováno v: In Ophthalmology March 2022 129(3):295-307

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.